Gabelli & Co Investment Advisers’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio SLXNW Stock Details SLXNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.56K	Hold
2025 Q1	$2.92K	Buy
2024 Q4	–	Sell
2024 Q3	$1.21K	Buy